Information  X 
Enter a valid email address

CareTech Holdings (CTH)

  Print      Mail a friend

Tuesday 07 May, 2019

CareTech Holdings

Block Admission, Issue of Shares and TVR

RNS Number : 1946Y
CareTech Holdings PLC
07 May 2019
 

 

For immediate release        


7 May 2019

 

 

  

CareTech Holdings PLC

                                                        ("CareTech" or "the Group")       

 

 

Block admission

 

Issue of shares

 

Total voting rights

 

CareTech Holdings PLC (AIM: CTH), a pioneering provider of specialist social care and education services to adults and children in the UK, announces that an application has been made to AIM for an additional block admission of 556,511 ordinary shares of 0.5 pence each ("Ordinary Shares") ("Block Admission").

The Block Admission relates to Ordinary Shares that will be issued from time to time in accordance with the exercise of options under the CareTech employee save-as-you earn share option schemes, the terms of which were announced on 18 March 2016 and 17 October 2017 ("Share Save Schemes").

All Ordinary Shares issued pursuant to the option schemes described above will rank pari passu with the existing Ordinary Shares. It is expected that the Block Admission will become effective on 8 May 2019.

In addition, 67,069 new Ordinary Shares have been issued in respect of satisfaction of the exercise of options under the Share Save Schemes and admission to trading of these shares will be pursuant to the Block Admission ("New Shares").

Total voting rights

Following the issue of the New Shares, the total number of voting rights of the Company is 108,947,309 shares. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in CareTech under the FCA's Disclosure and Transparency Rules.

The Company intends to notify on a monthly basis when there are changes to the issued share capital of the Company, and these monthly figures may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company, under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact: 

CareTech Holdings PLC                                               01707 601800

Farouq Sheikh, Executive Chairman

Gareth Dufton, Interim Group Finance Director

 

Buchanan (PR Adviser)                                                020 7466 5000

Mark Court

Sophie Wills

Tilly Abraham

 

Panmure Gordon (Nomad and Joint Broker)                020 7886 2500

Emma Earl

Freddy Crossley

Charles Leigh-Pemberton

 

WH Ireland (Joint Broker)                                             020 7220 1666

Adrian Hadden

Jessica Cave

Matthew Chan

 

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

About CareTech

 

CareTech Holdings plc is a leading provider of specialist social care and education services, supporting around 4,500 adults and children with a wide range of complex needs in more than 550 residential facilities and specialist schools around the UK and employing approximately 10,000 staff.

 

Committed to the highest standards of care and care governance, CareTech provides its innovative care pathways covering; Adult learning disabilities and specialist services; Children's residential and education services; and foster care.

 

CareTech, which was founded in 1993, began trading on the AIM market of the London Stock Exchange in October 2005 under the ticker symbol CTH.

 

For further information please visit: www.caretech-uk.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCDMGGKNNKGLZG

a d v e r t i s e m e n t